Project Grant HT9425261E308
Award Date 7/1/26
Completion Date 6/30/29
Dollars Obligated $652K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Gainesville, FL 32611, USA
Similar Awards
- Federal Grant Award Summary The University of Florida's Division of Sponsored Research received a $152,500 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) on August 1, 2025, with a completion date of July 31, 2027. This award supports advanced biomedical research focused on "Targeting TIE2 as a Novel Strategy in VEGFR Inhibitor-Resistant Angiosarcoma," with work being performed in Gainesville, Florida....
- Federal Grant Award Summary The University of Florida's Division of Sponsored Research received a $1,166,594 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) awarded September 1, 2025, with completion targeted for August 31, 2029. The research project, titled "Early Cardiac Biomarkers of Inflammation and Remodeling in Duchenne Muscular Dystrophy (DMD)," focuses on identifying and characterizing early cardiac...
- Federal Grant Award Summary The University of Central Florida Board of Trustees received a $1,771,271 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025, through August 31, 2028. The research initiative, titled "Targeting Lethal Prostate Cancer with Multifunctional Peptide Micelles that Disrupt Protein Folding," focuses on developing innovative therapeutic solutions for advanced...
- This federal Project Grant award of $551,881 from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) supports research at the University of Florida on a novel therapeutic approach for BRCA-mutated triple-negative breast cancer. The research aims to evaluate the dual inhibition of PARP and IL-6 as a potential treatment. The award period is from July 1, 2024 to June 30, 2027, providing funding to conduct this innovative, multi-year...
- Federal Project Grant Award Summary The University of Florida's Division of Sponsored Research received a $482,708 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to support research combining therapeutic acute intermittent hypoxia and respiratory-triggered diaphragm pacing to restore breathing function in chronic cervical spinal cord injury. The three-year project, which commenced September 30, 2025 and concludes...
- Federal Grant Award Summary Emory University's Office of Sponsored Programs received a $2.1 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the project "Investigating the Dark Proteome of Advanced Prostate Cancer." The award, effective September 1, 2026 through August 31, 2029, supports hypothesis-driven biomedical research designed to advance medical solutions for military service members and...
- Federal Project Grant Award Summary Florida State University's Sponsored Research Administration Division received a $885,480 project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025, through August 31, 2028. The award funds a three-year ecological momentary assessment (EMA) study investigating daily patterns and predictors of cognitive function in middle-aged and older adults with...
- Federal Grant Award Summary The University of Florida's Division of Sponsored Research received a $996,586 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective May 15, 2025, through May 14, 2028. This three-year research initiative investigates alcohol use as a moderating factor in serotonergic neurodegeneration during the early stages of Alzheimer's disease. The award supports hypothesis-driven biomedical...
- Federal Grant Award Summary New York University School of Medicine received a $750,962 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective June 15, 2026 through June 14, 2029. The award supports research investigating "Neoadjuvant Checkpoint and IL-6 Blockade: Mechanisms of Benefit and Toxicity," focusing on understanding the therapeutic mechanisms and adverse effects associated with combination...
- Federal Grant Award Summary H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. received a $397,788 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective June 1, 2026 through May 31, 2029. The award supports research investigating age-driven metastatic vulnerabilities in triple-negative breast cancer, a hypothesis-driven research initiative aligned with the DHA's mission to advance innovative...